Idexx Laboratories Sales & Marketing increased by 4.9% to $175.25M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.2%, from $156.22M to $175.25M. Over 4 years (FY 2021 to FY 2025), Sales & Marketing shows an upward trend with a 7.2% CAGR.
An increase may signal an aggressive growth strategy, while a decrease might indicate cost-cutting or reduced market investment.
Selling and marketing expenses include costs associated with advertising, sales force compensation, and promotional acti...
Common operating expense category; analyzed as a percentage of revenue to gauge marketing efficiency.
selling_and_marketing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $119.03M | $124.43M | $128.46M | $132.29M | $130.26M | $130.02M | $131.94M | $147.80M | $140.53M | $135.70M | $142.03M | $149.45M | $142.67M | $146.28M | $150.11M | $156.22M | $161.11M | $159.16M | $167.06M | $175.25M |
| QoQ Change | — | +4.5% | +3.2% | +3.0% | -1.5% | -0.2% | +1.5% | +12.0% | -4.9% | -3.4% | +4.7% | +5.2% | -4.5% | +2.5% | +2.6% | +4.1% | +3.1% | -1.2% | +5.0% | +4.9% |
| YoY Change | — | — | — | — | +9.4% | +4.5% | +2.7% | +11.7% | +7.9% | +4.4% | +7.7% | +1.1% | +1.5% | +7.8% | +5.7% | +4.5% | +12.9% | +8.8% | +11.3% | +12.2% |